{
    "SPADE_UN_13457": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13457",
            "Peptide Name": "RiLK1",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "VRLIVKVRIWRR",
            "Sequence Length": 12,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "[Ref.32971824] Gram-negative bacteria:E.coli (IC50 = 1.20 ± 0.10 μM, MBC = 2.0 μM), S. Typhimurium (IC50 = 1.30 ± 0.14\tμM, MBC = 2.5 μM);Gram-positive bacteria:S. aureus (IC50 = 1.98 ± 0.25 μM, MBC = 16.0 μM), L. monocytogenes (IC50 = 0.46 ± 0.01 μM, MBC = 2.0 μM);Fungi:C. albicans ATCC 14053, A. brasiliensis ATCC 9341. Susceptibility testing clearly showed that RiLK1 was very effective, being able to inhibit 100% growth of both fungi at 25 μM concentration (MFC).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.32971824] It was observed that the cell viability was recorded as 98%, 98.7%, and 98.9% at the concentrations of RiLK1 (10, 25, 50 μM)",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Without SDS: 1.2% α-helix, 47.3% β-sheet, 51.5% random; t = 0 h with SDS:  7.4% α-helix, 51.4% β-sheet, 41.3% random; t = 5 min with SDS:  4.4% α-helix, 53.4% β-sheet, 42.2% random; t = 30 min with SDS: 11% α-helix, 48.7% β-sheet, 40.3% random; t = 1 h with SDS: 9.8% α-helix, 51.1% β-sheet, 39.1% random; t = 5 h with SDS: 6.7% α-helix, 54% β-sheet, 39.3% random; t = 6 h with SDS: 8% α-helix, 52% β-sheet, 40.1% random; t = 24 h with SDS: 8.4% α-helix, 53.6% β-sheet, 38% random",
            "Formula": "C74H132N26O13",
            "Mass": 1594.01,
            "PI": 12.0,
            "Net Charge": 5,
            "Hydrophobicity": 0.22,
            "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "RiLK1 exerted potent killing effects against the clinical isolate (MBC = 1.25 M), two-fold lower than those observed against the strain isolated from food products and those determined with the parental peptide 1018-K6 against ACSSuT strain, thus, suggesting that RiLK1 might have a high potential also in the medical field.",
            "Literature": [
                {
                    "Title": "A Safe and Multitasking Antimicrobial Decapeptide The Road from De Novo Design to Structural and Functional Characterization",
                    "Pubmed ID": "32971824",
                    "Reference": "Int J Mol Sci. 2020 Sep 22;21(18)6952. doi 10.3390/ijms21186952.",
                    "Author": "Agrillo B, Proroga YTR, Gogliettino M, Balestrieri M, Tatè R, Nicolais L, Palmieri G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32971824"
                }
            ],
            "Frequent Amino Acids": "RVI",
            "Absent Amino Acids": "ACDEFGHMNOPQSTUY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 8,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_23009",
                    "Similarity": 1.0,
                    "Sequence": "RLIVKVRIWRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_05263",
                    "Similarity": 1.0,
                    "Sequence": "VRIGWRRVK"
                },
                {
                    "SPADE_ID": "SPADE_UN_13037",
                    "Similarity": 1.0,
                    "Sequence": "VRIWRR"
                }
            ]
        }
    }
}